CEO Update | 13 December 2021

A new era for the BIA

Following the Annual General Meeting (AGM), the BIA would like to announce its next Chair and members who have been elected to its Board of Directors. The AGM took place on Tuesday 19th October and the new board members were voted for by the BIA’s membership in the weeks leading up to the meeting.

Dr Ruth McKernan CBE, the current Chair of the Association, has completed her term and the Board voted for the next Chair to be Dan Mahony of Evotec during the last Board meeting and his appointment was announced at the AGM. He will begin the role in the New Year and has been on the BIA board for five years.

The BIA staff has also grown with the addition of a new Marketing function. The appointments include Alina O’Keeffe as the new Head of Marketing and Membership Communications and Erica Hollingsworth who has joined as the Marketing and Communications Executive. Both these appointments will enable the BIA to better deploy its messages and communications across the industry and to its members.

Three new starters have also been recruited into the Policy and Public Affairs team, Linda Bedenik, Emma Lawrence and Rosie Lindup have all joined the Association and will provide significant expertise and delivery in one of the key areas for the BIA.

Michael McGivern has also been promoted to Head of Membership and he will take the lead in all matters of member recruitment and retention across the Association.

Knowledge Transfer Network (KTN) lifetime achievement award

Congratulations to Jean Aligorgi was presented with the KTN’s lifetime achievement award. Jean has been with the KTN for 16 years and was one of the early members of the team who originally helped set up bioProcessUK.

Steve Bates OBE
CEO, BioIndustry Association

More news and updates

Stablepharma is delighted to announce another new recruit to the Science Team in Spain

Stablepharma announce another new recruit to the Science team in Madrid, Spain based at Stablepharma’s R&D Center of Excellence (CoE) in Qube Technology Park

Medannex’s monoclonal antibody MDX-124 highly active in pancreatic cancer models

Data shows powerful synergy in combination with standard cancer treatments

CEO Update | 24 January 2022

I am looking forward to our first in-person events of 2022 this week, headlined by the BIA’s Annual Gala Dinner. This is a chance to celebrate the fantastic work undertaken by the sector throughout 2021 and raise money for our Charity Partner of the Year, Kidney Research UK. There are a few individual tickets left, so do book quickly if you are interested in attending.

Virology Research Services Chooses Discovery Park as it relocates London team

A team of virologists move to Discovery Park to expand operations. Demand for lab and manufacturing space continues at Discovery Park to support the UK’s booming life science industry.